BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4
90139 results:

  • 1. Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women.
    Nykänen A; Sudah M; Masarwah A; Vanninen R; Okuma H
    Sci Rep; 2024 May; 14(1):10001. PubMed ID: 38693256
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. pDNA-tachyplesin treatment stimulates the immune system and increases the probability of apoptosis in MC4-L2 tumor cells.
    Mahmoudi-Filabadi F; Doosti A
    Amino Acids; 2024 May; 56(1):34. PubMed ID: 38691208
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
    Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
    Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Surgical Treatment of breast Lymphedema: A Distinct Pathology With Unique Challenges.
    Szymanski K; Chun Fat S; Brazio PS
    Ann Plast Surg; 2024 May; 92(5S Suppl 3):S315-S319. PubMed ID: 38689412
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.
    Inakami K; Fujita N; Iguchi C; Enomoto Y; Minohata J; Sata A; Miyagawa Y; Yanagisawa T; Saitoh T; Nomura T; Sawai Y; Takahara K; Kasugai T; Shiba E
    J Med Case Rep; 2024 May; 18(1):214. PubMed ID: 38689362
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.
    Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL
    Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Diffusion probabilistic versus generative adversarial models to reduce contrast agent dose in breast MRI.
    Müller-Franzes G; Huck L; Bode M; Nebelung S; Kuhl C; Truhn D; Lemainque T
    Eur Radiol Exp; 2024 May; 8(1):53. PubMed ID: 38689178
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A Comparative Analysis of Implant-sparing Plan
    Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
    In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evolution of neoadjuvant therapy for breast cancer regimens over 12 years and pathologic response rates according to tumor subtypes and clinical stage: A single-center retrospective study.
    Li Z; Wang Y
    J Cancer Res Ther; 2024 Apr; 20(2):608-614. PubMed ID: 38687931
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Addition of Contrast-enhanced Mammography to Tomosynthesis for breast cancer Detection in Women with a Personal History of breast cancer: Prospective TOCEM Trial Interim Analysis.
    Berg WA; Berg JM; Bandos AI; Vargo A; Chough DM; Lu AH; Ganott MA; Kelly AE; Nair BE; Hartman JY; Waheed U; Hakim CM; Harnist KS; Reginella RF; Shinde DD; Carlin BA; Cohen CS; Wallace LP; Sumkin JH; Zuley ML
    Radiology; 2024 Apr; 311(1):e231991. PubMed ID: 38687218
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. BI-RADS Category Assignments by GPT-3.5, GPT-4, and Google Bard: A Multilanguage Study.
    Cozzi A; Pinker K; Hidber A; Zhang T; Bonomo L; Lo Gullo R; Christianson B; Curti M; Rizzo S; Del Grande F; Mann RM; Schiaffino S
    Radiology; 2024 Apr; 311(1):e232133. PubMed ID: 38687216
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Doxorubicin, doxorubicinol, cardiotoxicity, breast cancer, volumetric absorptive microsampling, LC-MS/MS.
    Chairunnisa DF; Harahap Y; Juanita M; Syafhan NF; Purwanto DJ
    Pak J Biol Sci; 2024 Mar; 27(3):125-131. PubMed ID: 38686734
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identifying priority areas to support primary care engagement in breast cancer survivorship care: A Delphi study.
    Mikesell L; O'Malley DM; Kurtzman RT; Howard J; Bates B; Hemler JR; Fadem SJ; Ferrante JM; Bator A; Hudson SV; Crabtree BF
    Cancer Med; 2024 May; 13(9):e7219. PubMed ID: 38686635
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Metochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer.
    Zhou J; Wan F; Xiao B; Li X; Peng C; Peng FU
    Oncol Res; 2024; 32(5):943-953. PubMed ID: 38686052
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Neoadjuvant Chemotherapy in Patients with HER2-Negative breast cancer: A Report from Clinical breast cancer Registry of Iran.
    Roudini K; Mirzania M; Yavari T; Seyyedsalehi MS; Nahvijou A; Zebardast J; Saadat M; Khajeh-Mehrizi A
    Arch Iran Med; 2024 Apr; 27(4):206-215. PubMed ID: 38685847
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Germline biallelic brca2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance.
    Cui J; Liu X; Shang Q; Sun S; Chen S; Dong J; Zhu Y; Liu L; Xia Y; Wang Y; Xiang L; Fan B; Zhan J; Zhou Y; Chen P; Zhao R; Liu X; Xing N; Wu D; Shi B; Zou Y
    Mol Cancer; 2024 Apr; 23(1):86. PubMed ID: 38685067
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
    Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
    Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Synthesis, molecular docking studies and biological evaluation of N-(4-oxo-2-(trifluoromethyl)-4H-chromen-7-yl) benzamides as potential antioxidant, and anticancer agents.
    Jorepalli S; Adikay S; Chinthaparthi RR; Gangireddy CSR; Koduru JR; Karri RR
    Sci Rep; 2024 Apr; 14(1):9866. PubMed ID: 38684797
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cytotoxic and apoptotic effects of Ferula gummosa Boiss: extract on human breast adenocarcinoma cell line.
    Rashidi R; Roohbakhsh A; Mohtashami L; Mobasheri L; Kheradmand H; Amiri MS; Ghorbani A; Mousavi SH
    Mol Biol Rep; 2024 Apr; 51(1):592. PubMed ID: 38683376
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4507.